Good Documentation Practices for Clinical Trials

Good Documentation Practices for Clinical Trials



This webinar is intended to help you adequately implement Good Clinical Practices (GCP): in particular, documentation requirements during clinical trials for both drugs and medical devices.

To adequately implement GCPs, there are a set of standard operating procedures (SOPs) to be established and maintained at any given facility, to the extent applicable, as a sponsor, clinical investigators, monitors, and CROs, etc.

The documentation requirements including a set of SOPs with key elements to be contained in the SOP will be discussed.

In this 60-min webinar, you will have unparalleled opportunities to bring great value and benefits to your organization and to greatly improve your GCPs with increased awareness of the needs – sustainable compliance and patient safety.

Areas to be Covered:

Statutes, Regulations and Definitions
Regulatory Requirements for INDs and IDEs.
Clinical Trials
Clinical Investigators (CI)
Institutional Review Boards (IRBs)
Sponsors and Monitors
Contract Research Organizations (CROs)
ICH-GCP Guidelines
ISO 14155
List of SOPs and Adequate Documentation
Key Elements in the SOPs
Common GCP Deficiencies in EU and US
Enforcement Actions
Lessons Learned

Who will Benefit:

Clinical Affairs
Regulatory Affairs
Quality Assurance
Senior Management
Anyone Interested in the Topic

Dr. Mukesh Kumar

Dr. Mukesh Kumar is a Washington DC-based consultant in regulatory affairs and quality assurance for manufacturers and developers of FDA-regulated products. He and leads the Regulatory Affairs and Quality Assurance departments at Amarex, a full service pharmaceutical product development company based in Germantown, MD. His key expertise is in regulatory affairs, clinical trials and multinational project management for medicinal and diagnostic products. He has been involved in about 100 clinical trials in more than 40 countries, has made several hundred US FDA submissions, and arranged a number of meetings with the US FDA. In addition, he has had made regulatory submission in the EU and India. He has conducted GCP, GLP, GMP and GACP audits in the US and several countries in Europe and Asia. He has conducted numerous training workshops in FDA compliance related issues. He has authored numerous articles in peer-reviewed journals. He is a well known expert in global regulatory affairs and has been an invited speaker at several professional and academic organizations worldwide. Dr. Kumar is a PhD in Biochemistry and has worked as a research scientist at the NIH, Baylor College of Medicine, Houston, and premier institutions in India. He is a certified regulatory affairs professional by the Regulatory Affairs Professional Society, USA.

Leave a Reply

Your email address will not be published. Required fields are marked *